182 related articles for article (PubMed ID: 29770217)
1. Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.
Naganuma M; Motooka Y; Sasaoka S; Hatahira H; Hasegawa S; Fukuda A; Nakao S; Shimada K; Hirade K; Mori T; Yoshimura T; Kato T; Nakamura M
SAGE Open Med; 2018; 6():2050312118772475. PubMed ID: 29770217
[TBL] [Abstract][Full Text] [Related]
2. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
3. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases.
Hatahira H; Abe J; Hane Y; Matsui T; Sasaoka S; Motooka Y; Hasegawa S; Fukuda A; Naganuma M; Ohmori T; Kinosada Y; Nakamura M
J Pharm Health Care Sci; 2017; 3():19. PubMed ID: 28729910
[TBL] [Abstract][Full Text] [Related]
5. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Hasegawa S; Matsui T; Hane Y; Abe J; Hatahira H; Motooka Y; Sasaoka S; Fukuda A; Naganuma M; Hirade K; Takahashi Y; Kinosada Y; Nakamura M
PLoS One; 2017; 12(7):e0182045. PubMed ID: 28732067
[TBL] [Abstract][Full Text] [Related]
7. Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database.
Matsumoto K; Nakao S; Hasegawa S; Matsui T; Shimada K; Mukai R; Tanaka M; Uranishi H; Nakamura M
SAGE Open Med; 2020; 8():2050312120918264. PubMed ID: 32528682
[TBL] [Abstract][Full Text] [Related]
8. Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.
Sakaeda T; Kadoyama K; Okuno Y
Int J Med Sci; 2011; 8(6):487-91. PubMed ID: 21897761
[TBL] [Abstract][Full Text] [Related]
9. Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data.
Feng G; Zhou X; Chen J; Li D; Chen L
Front Oncol; 2022; 12():1012093. PubMed ID: 36713566
[TBL] [Abstract][Full Text] [Related]
10. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
[TBL] [Abstract][Full Text] [Related]
11. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
[TBL] [Abstract][Full Text] [Related]
12. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database.
Abe J; Umetsu R; Mataki K; Kato Y; Ueda N; Nakayama Y; Hane Y; Matsui T; Hatahira H; Sasaoka S; Motooka Y; Hara H; Kato Z; Kinosada Y; Inagaki N; Nakamura M
J Pharm Health Care Sci; 2016; 2():14. PubMed ID: 27330825
[TBL] [Abstract][Full Text] [Related]
14. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
15. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
[TBL] [Abstract][Full Text] [Related]
16. Platinum-induced hearing loss after treatment for childhood cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
[TBL] [Abstract][Full Text] [Related]
17. The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.
Vermorken JB
Int J Gynecol Cancer; 2001; 11 Suppl 1():21-30. PubMed ID: 11488999
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis.
Matsumoto K; Hasegawa S; Nakao S; Shimada K; Mukai R; Tanaka M; Satake R; Yoshida Y; Goto F; Inoue M; Ikesue H; Iguchi K; Hashida T; Nakamura M
SAGE Open Med; 2020; 8():2050312120974176. PubMed ID: 33282307
[TBL] [Abstract][Full Text] [Related]
19. Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database.
Hatahira H; Hasegawa S; Sasaoka S; Kato Y; Abe J; Motooka Y; Fukuda A; Naganuma M; Nakao S; Mukai R; Shimada K; Hirade K; Kato T; Nakamura M
J Pharm Health Care Sci; 2018; 4():32. PubMed ID: 30574336
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
Specenier PM; Ciuleanu T; Latz JE; Musib LC; Darstein CL; Vermorken JB
Cancer Chemother Pharmacol; 2009 Jul; 64(2):233-41. PubMed ID: 19011858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
